Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 05-oct-2026 · last seen 05-oct-2026

NLRP3 Inflammasome in Aging and Neurodegeneration

Current understanding

The NLRP3 inflammasome is a cytosolic multiprotein sensor that converts upstream signals (mtDNA leak, oxidized lipids, protein aggregates, lysosomal damage) into IL-1β/IL-18 release and pyroptosis, and is repeatedly implicated across aging-tissue contexts (T2DM–AD balance circuits, Gaucher microglia, AT2R-deficient hearts, LMNA progeria) as a convergent inflammatory effector [expert-opinion]. A 2026 review proposes it as one leg of a self-sustaining Autophagy–Senescence–Inflammasome (ASI) triad in brain aging and neurodegeneration [expert-opinion]. Human translation remains inferential — most direct evidence is preclinical or mechanistic, and inflammasome-targeted drugs have not demonstrated healthspan effects.

Evidence log

Open questions

Related

Contributing findings

pubmed meta analysis human-rct
Electroacupuncture Targeting the NLRP3 Inflammasome in Senescence‑associated Cognitive Impairment: Mechanistic Synthesis and Meta‑analysis of Clinical Randomized Controlled Trials.
05-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
Functional Shift of NLRP3 Inflammasome Activity in Aged Macrophages.
28-sep-2026 novelty 3 per-area 3 strengthens
pubmed review
The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?
08-jul-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18